European Institute

Article Information

Category: Roundtables

Created on 30 April 2013

On April 30, 2013, The European Institute held a seminar in cooperation with the Jean Monnet Foundation for Europe to examine the challenges and opportunities for transatlantic cooperation in multilateral governance, in monetary, trade and investment policy, and in medical science research and innovation. Speakers included: The Honorable José Maria Gil-Robles, President, The Jean Monnet Foundation for Europe & former President of the European Parliament; François Rivasseau, Deputy Head of the Delegation of the European Union to the United States; Ambassador Ioannis Vrailas, Deputy Head of the Delegation of the European Union to the United Nations; Ambassador Kurt Volker, Executive Director, McCain Institute for International Leadership, Arizona State University & former U.S. Ambassador to NATO; Antonio de Lecea, Principal Advisor, Delegation of the European Union to the United States; Mark Sobel, Deputy Assistant Secretary for International Monetary and Financial Policy, U.S. Department of the Treasury; Michael Smart, Vice President, Rock Creek Global Advisors LLC; James Mendenhall, Counsel, International Trade & Dispute Resolution Group, Sidley Austin LLP; The Honorable Bart Gordon, Partner, K&L Gates & Former Chairman, U.S. House of Representatives Committee on Science and Technology; The Honorable Chaka Fattah, Member, Committee on Appropriations & Ranking Member, Subcommittee on Commerce, Justice, Science & Related Agencies, U.S. House of Representatives; Dr. James Gavigan, Minister-Counselor & Head of the Science, Technology & Education Section, Delegation of the European Union; Professor Henry Markram, Founder & Director, École Polytechnique Fédérale de Lausanne (EPFL) Brain Mind Institute & Coordinator, Human Brain Project; and Dr. Adrian Ivinson, Director, Harvard NeuroDiscovery Center, Harvard University Medical School.

Article Information

Category: Roundtables

Created on 11 April 2013

On April 11, 2013, the European Institute in partnership with the Embassy of Ireland and the European Commission organized a seminar focused on the opportunities in health research in Europe. The plenary session of this day-long event featured His Excellency Michael Collins, Ambassador of Ireland to the United States and His Excellency João Vale de Almeida, Ambassador of the European Union to the United States. Both Ambassadors stressed the importance of research, especially in Europe, and also touched upon opportunities for transatlantic scientific cooperation. Joelle Attinger, President of the European Institute, offered the welcoming remarks and James Gavigan, Head of the Science & Technology Section at the Delegation of the European Union to the United States moderated the event.

Article Information

Category: Roundtables

Created on 13 February 2013

On February 13, 2013, The European Institute hosted a discussion with Robert-Jan Smits, Director General of DG Research and Innovation at the European Commission, on the EU’s new strategic approach to international research and innovation cooperation. With U.S. President Barack Obama’s announcement of the launch of talks for a comprehensive Transatlantic Trade and Investment Partnership, Mr. Smits said that both sides of the Atlantic were “rediscovering each other”, and that the common understanding of the potency of innovation as a prime motor for sustainable economic growth, job creation and global competitiveness augured well for increased European-American cooperation. Anna McDermott-Vitak, Executive Director of Global Government Affairs at Amgen, Inc, offered opening remarks, and Dr. Elias Carayannis, Professor of Science, Technology, Innovation and Entrepreneurship at George Washington University, moderated the lively exchange. 

Mr. Smits' remarks are available here.

Article Information

Category: Roundtables

Created on 25 October 2012

On October 25, 2012, The European Institute, in cooperation with the Embassy of Belgium and the Embassy of Switzerland held a special seminar on transatlantic cooperation in stemming the spread of falsified medications.  Mark Witzal, Deputy Director of the National Intellectual Property Rights Coordination Center, U.S. Immigrations and Customs Enforcement, Homeland Security Investigations presented the keynote address.  Panelists in the first session: Bernard Frahi, Vice President for Corporate Economic Security at Sanofi; Ambassador Richard Kauzlarich, Deputy Director at the Terrorism, Transnational Crime & Corruption Center and Adjunct Professor at George Mason University’s School of Public Policy; and Jeffrey Gren, Director of the Office of Health and Consumer Goods at the U.S. Department of Commerce discussed the security, economic and public health risks of falsified medications.  The panel was moderated by Susan Reardon, Director of International Policy, Worldwide Government Affairs and Policy at Johnson & Johnson.  Panelists in the second session: John Roth, Director of the Office of Criminal Investigations at the U.S. Food and Drug Administration; Patrick Byrne, Europol Senior Representative and Head of Europol Delegation at the Delegation of the European Union to the United States; Chief Commissioner Patrick Stevens, Counselor and Belgian Police Liaison Officer at the Embassy of Belgium; Kelley Friedgen, Senior Corporate Counsel at Genentech and Legal Advisor to the Genentech Counterfeit Prevention and Response Task Force; and Jeannie Salo, Director for Global Anti-Counterfeiting, Office of International Government Affairs at Eli Lilly and Company examined public and private sector solutions to the fast-growing falsified medications problem.  This panel was moderated by Frédéric Badey, Senior Director, International Public Affairs Coordination, Sanofi.